Pathway-Based Analysis of Genome-Wide siRNA Screens Reveals the Regulatory Landscape of App Processing-Reference-Cited by-同舟云学术

Pathway-Based Analysis of Genome-Wide siRNA Screens Reveals the Regulatory Landscape of App Processing

Published:2015-02-27 Issue:2 Volume:10 Page:e0115369
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Camargo Luiz Miguel,Zhang Xiaohua Douglas,Loerch Patrick,Caceres Ramon Miguel,Marine Shane D.,Uva Paolo,Ferrer Marc,Rinaldis Emanuele de,Stone David J.,Majercak John,Ray William J.,Yi-An Chen,Shearman Mark S.,Mizuguchi Kenji

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference74 articles.

1. Pathways towards and away from Alzheimer's disease;MP Mattson;Nature,2004

2. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics;J Hardy;Science,2002

3. Therapeutic strategies for Alzheimer's disease;MS Wolfe;Nat Rev Drug Discov,2002

4. Protease inhibitors as potential disease-modifying therapeutics for Alzheimer's disease;D Beher;Expert Opin Investig Drugs,2005

5. Presenilin diversifies its portfolio;AL Parks;Trends Genet,2007

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Step by step: towards a better understanding of the genetic architecture of Alzheimer’s disease;Molecular Psychiatry;2023-05-02

2. The Role of MEF2 Transcription Factor Family in Neuronal Survival and Degeneration;International Journal of Molecular Sciences;2023-02-04

3. Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: Implications in Alzheimer’s disease and normal physiology;Frontiers in Cell and Developmental Biology;2022-07-26

4. Progress on the roles of MEF2C in neuropsychiatric diseases;Molecular Brain;2022-01-06

5. MEF2C ameliorates learning, memory, and molecular pathological changes in Alzheimer’s disease <italic>in vivo</italic> and<?A3B2 ACK?><italic>in vitro</italic>;Acta Biochimica et Biophysica Sinica;2021-12-28